Dachaigh › Galar Depressive Mòr › California
Sgrùdaidhean clionaigeach Galar Depressive Mòr ann an California
Tha 52 sgrùdaidhean airson Galar Depressive Mòr a’ lorg phàirtichean aig làraichean ann an California.
Bailtean ann an California
- San Diego16 sgrùdaidhean
- Orange13 sgrùdaidhean
- Glendale12 sgrùdaidhean
- Los Angeles12 sgrùdaidhean
- Concord12 sgrùdaidhean
- Oceanside9 sgrùdaidhean
- San Bernardino8 sgrùdaidhean
- San Francisco8 sgrùdaidhean
- San Jose7 sgrùdaidhean
- Mountain View7 sgrùdaidhean
- Chino6 sgrùdaidhean
- Bellflower6 sgrùdaidhean
- Garden Grove4 sgrùdaidhean
- Santa Monica4 sgrùdaidhean
- Long Beach4 sgrùdaidhean
- Burbank4 sgrùdaidhean
- Anaheim3 sgrùdaidhean
- Mission Viejo3 sgrùdaidhean
- Downey3 sgrùdaidhean
- Irvine3 sgrùdaidhean
Teacsa sgrùdaidh oifigeil (Beurla)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Irvine Clinical Research, Irvine
- Healthy Brain Clinic, Long Beach
- Oakland Clinical, Oakland
- agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- CI Trials, Bellflower
- Behavioral Research Specialists LLC, Glendale
- Excell Research Inc, Oceanside
- agus 3 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- PAMOJA Clinical Institute LLC, Anaheim
- Axiom Research, Colton
- Behavioral Research Specialists LLC, Glendale
- agus 3 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06559306A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Buena Park Research Center, Buena Park
- Inland Psychiatric Medical Group, Inc. - Chino, Chino
- Synergy Research - San Diego, Lemon Grove
- agus 3 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07621237Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- CNRI-Los Angeles, LLC, Pico Rivera
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05850689A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Behavioral Research Specialists, LLC, Glendale
- CalNeuro Research Group, Los Angeles
- Lipov Medical Group, Los Angeles
- agus 4 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Garden Grove
- Vanda Investigational Site, Orange
- Vanda Investigational Site, Redlands
- agus 2 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Chino
- Neurocrine Clinical Site, Fresno
- Neurocrine Clinical Site, Long Beach
- agus 3 a bharrachd
A’ fastadhÌre 4
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT07105111Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression: A Home-Based Feasibility and Safety Study
- UCSD Interventional Psychiatry, San Diego
A’ fastadh
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07217223A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
- Seaport Investigator Site, Chino
- Seaport Investigator Site, Garden Grove
- Seaport Investigator Site, Glendale
- agus 2 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07065240ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Inland Psychiatric Medical Group, Chino
- Behavioral Research Specialists, LLC, Glendale
- Kadima Neuropsychiatry Institute, La Jolla
- agus 1 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07284667Near Infrared Spectroscopy (NIRS) for Assessment of Depression
- San Francisco Veterans Affairs Medical Center, San Francisco
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT04061148A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Clinical Innovations Inc, Bellflower
- Center for Neurohealth, La Jolla
- Artemis Institute for Clinical Research, San Diego
- agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Bellflower
- Draig Clinical Site, Costa Mesa
- Draig Clinical Site, Lafayette
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- USC University Hospital, Los Angeles
- UCLA Department of Psychiatry, Los Angeles
- University of California at Davis, Sacramento
A’ fastadh
Aoisean 22 gu 70 · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT06423430A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Oceanside
- Draig Clinical Site, San Diego
- Draig Clinical Site, Torrance
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT07300969Virtual Reality-Enhanced Behavioral Activation for Older Adults With Depression
- Stanford University, Stanford
A’ fastadh
Aoisean 65 agus nas sine · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT07188623Enhancing Veteran-Clinical Collaboration in VA PRRCs
- VA San Diego Healthcare System, San Diego, CA, San Diego
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT06898879NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Glendale
- Neurocrine Clinical Site, Redlands
- Neurocrine Clinical Site, San Francisco
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT06911112Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMS
- Stanford Hospital, Stanford
A’ fastadh
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT04870255Pain and Major Depressive Disorder
- UCLA Semel Institute, Los Angeles
A’ fastadhA’ toirt iomradh air pàigheadh do chom-pàirtichean
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT04556890A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- ATP Clinical Research Orange County, Orange
- Kadima Neuropsychiatry Institute, San Diego
- UCSF Department of Neurology, San Francisco
- agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT07592689NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Chino
- Neurocrine Clinical Site, Los Angeles
- Neurocrine Clinical Site, Stanford
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT06963021A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Accellacare - Moorpark, Moorpark
- ATP Clinical Research, Orange
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT07412756Closed-Loop Deep Brain Stimulation for Major Depression
- University of California, San Francisco, San Francisco
A’ fastadh
Aoisean 22 gu 70 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT04004169A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Behavioral Research Specialists, Llc, Glendale
- Irvine Clinical Research, Irvine
- CalNeuro Research Group, Inc., Los Angeles
- agus 6 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06775379Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Irvine Clinical Research, Irvine
- CalNeuro Research Group, Los Angeles
- Sunwise Clinical Research LLC, Walnut Creek
A’ fastadhÌre 2
Aoisean 18 gu 64 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06547489A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Catalina Research Institute, LLC, Montclair
- Excell Research, Inc, Oceanside
- Anderson Clinical Research, Redlands
- agus 3 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 64 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT07115329A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Oceanside
- Neurocrine Clinical Site, Orange
- Neurocrine Clinical Site, San Jose
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT07196501Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Glendale
- Neurocrine Clinical Site, Los Angeles
- Neurocrine Clinical Site, Oceanside
- agus 5 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT06966401Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Bellflower
- Clinical Research Site, Chino
- Clinical Research Site, Glendale
- agus 7 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT07484217Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
- Acacia Clinics, Sunnyvale
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 16 Iuch 2026 · NCT06376734Sleep TMS for Depression
- Stanford University, Stanford
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 23 Ògmh 2026 · NCT06824415A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Advanced Research Center /ID# 277537, Anaheim
- Sun Valley Research Center /ID# 277513, Imperial
- Synergy San Diego /ID# 277553, Lemon Grove
- agus 4 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 15 Ògmh 2026 · NCT07276997Evaluating tDCS Brain-stimulation in Depression Using MRI
- University of California Los Angeles (UCLA), Los Angeles
A’ fastadh
Aoisean 20 gu 55 · Gach gnè · Air ùrachadh 8 Ògmh 2026 · NCT05598034A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- CenExel, Garden Grove
- Behavioral Research Specialists, LLC, Glendale
- Kadima Neuropsychiatry Institute, La Jolla
- agus 2 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 11 Cèit 2026 · NCT06524830Mindfulness Engaged Neurostimulation for Depression (MEND II)
- UC San Diego Health Psychiatry, San Diego
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT07512284Regulation of Affect and Physiology in Depression
- University of Southern California, Los Angeles
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 27 · Gach gnè · Air ùrachadh 4 Cèit 2026 · NCT06345859Maintenance rTMS for Depression (Maitr-De)
- University of California, San Diego, San Diego
A’ fastadh
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 29 Gibl 2026 · NCT06938841ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
- Salma Health, La Jolla
- Salma Health, Laguna Hills
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Gibl 2026 · NCT07528014Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.